Inhibition of In-Stent Stenosis by Oral Administration of Bindarit in Porcine Coronary Arteries | Arteriosclerosis, Thrombosis, and Vascular Biology
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis | Journal of Neuroinflammation | Full Text
BINDARIT | New Drug Approvals
Amelioration of alphavirus‐induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins - Rulli - 2009 - Arthritis & Rheumatism - Wiley Online Library
Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching | PLOS ONE
Original Article Bindarit alleviates inflammation and early brain injury following experimental subarachnoid hemorrhage in rat
Bindarit, an Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by Chikungunya Virus Infection | Journal of Virology
Bindarit (AF2838) | MCP/CCL Inhibitor | MedChemExpress
Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties | Cellular & Molecular Immunology
Bindarit (AF 2838) | ≥99%(HPLC) | Selleck | Immunology & Inflammation related 阻害剤
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models | SpringerLink
Study of the immuno-modulatory activity of bindarit on LPS-stimulated... | Download Scientific Diagram
Bindarit, an Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by Chikungunya Virus Infection | Journal of Virology
Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching | PLOS ONE
Bindarit - an overview | ScienceDirect Topics
Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching | PLOS ONE
BINDARIT | New Drug Approvals
Life | Free Full-Text | Monocyte Chemotactic Proteins Mediate the Effects of Hyperglycemia in Chondrocytes: In Vitro Studies
Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties | Cellular & Molecular Immunology
JCM | Free Full-Text | Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade
The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model | Journal of Neuroscience
In vitro and in silico studies of the physical interaction between... | Download Scientific Diagram
Original Article Bindarit alleviates inflammation and early brain injury following experimental subarachnoid hemorrhage in rat
Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial | tctmd.com
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal m
Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial | tctmd.com
Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching | PLOS ONE
Inhibition of In-Stent Stenosis by Oral Administration of Bindarit in Porcine Coronary Arteries | Arteriosclerosis, Thrombosis, and Vascular Biology
